- Home
- GOSS vs EFT Comparison
GOSS vs EFT Comparison
Compare GOSS & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- EFT
- Stock Information
- Founded
- GOSS 2015
- EFT 2004
- Country
- GOSS United States
- EFT United States
- Employees
- GOSS N/A
- EFT N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- EFT Finance Companies
- Sector
- GOSS Health Care
- EFT Finance
- Exchange
- GOSS Nasdaq
- EFT Nasdaq
- Market Cap
- GOSS 347.8M
- EFT 327.7M
- IPO Year
- GOSS 2019
- EFT N/A
- Fundamental
- Price
- GOSS $2.47
- EFT $12.08
- Analyst Decision
- GOSS Strong Buy
- EFT
- Analyst Count
- GOSS 4
- EFT 0
- Target Price
- GOSS $8.50
- EFT N/A
- AVG Volume (30 Days)
- GOSS 3.1M
- EFT 100.8K
- Earning Date
- GOSS 08-05-2025
- EFT 01-01-0001
- Dividend Yield
- GOSS N/A
- EFT 10.63%
- EPS Growth
- GOSS N/A
- EFT N/A
- EPS
- GOSS N/A
- EFT 1.73
- Revenue
- GOSS $40,237,000.00
- EFT N/A
- Revenue This Year
- GOSS N/A
- EFT N/A
- Revenue Next Year
- GOSS $30.65
- EFT N/A
- P/E Ratio
- GOSS N/A
- EFT $7.62
- Revenue Growth
- GOSS N/A
- EFT N/A
- 52 Week Low
- GOSS $0.66
- EFT $11.10
- 52 Week High
- GOSS $2.65
- EFT $13.44
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- EFT 43.69
- Support Level
- GOSS $2.38
- EFT $12.00
- Resistance Level
- GOSS $2.65
- EFT $12.24
- Average True Range (ATR)
- GOSS 0.15
- EFT 0.08
- MACD
- GOSS 0.03
- EFT 0.01
- Stochastic Oscillator
- GOSS 76.67
- EFT 63.16
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest
Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.